Growth ETF (IWF) Hits New 52-Week High

IWF

For investors seeking momentum, iShares Russell 1000 Growth ETF (IWF - Free Report) is probably on radar now. The fund just hit a 52-week high, and is up roughly 23.2% from its 52-week low price of $87.38/share.

But are more gains in store for this ETF? Let’s take a quick look at the fund and the near-term outlook on it to get a better idea on where it might be headed:

IWF in Focus    

This fund offers exposure to U.S. companies whose earnings are expected to grow at an above-average rate relative to the market. Holding a broad basket of 608 securities, the fund is well spread across components with none holding more than 5.54% of assets. It is a large cap centric fund with key holdings in information technology, consumer discretionary and healthcare. The product charges 20 bps in fees per year (see: all the Large Cap ETFs here).

Why the Move?

The growth space of the broad U.S. stock market has been an area to watch lately given its outperformance on Trump euphoria and improving domestic fundamentals. Growth stocks are leading the rally to start the year, as these tend to outperform in a trending market (i.e. a market characterized by a prolonged uptrend). Additionally, solid manufacturing and industrial activities across the globe are giving a boost to these stocks.

More Gains Ahead?

Currently, IWF has a Zacks ETF Rank of 3 or ‘Hold’ rating with a Medium risk outlook. Therefore, it is hard to get a handle on its future returns in one way or the other. However, many of the segments that make up this ETF have a strong Zacks Industry Rank, so there is definitely some promise for those who want to ride this surging ETF a little further.

Want key ETF info delivered straight to your inbox?

Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>

Zacks Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.

This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.

Free: See Our Top Stock and 4 Runners Up >>